Screener
Arcus Biosciences RCUS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development (Includes $2, $11, $2 and $6 from a related party) | 113 | 139 | 235 | 261 |
| General and administrative(Includes $—, $2, $— and $2 from a related party) | 24 | 29 | 53 | 57 |
| Total operating expenses | 137 | 168 | 288 | 318 |
| Loss from operations | (96) | (8) | (230) | (130) |
| Non-operating income (expense): | ||||
| Interest and other income, net | 8 | 10 | 17 | 21 |
| Interest expense | (3) | (2) | (6) | (3) |
| Total non-operating income, net | 5 | 8 | 11 | 18 |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's operating income?
- Arcus Biosciences (RCUS) reported operating income of -$96M in Q2 2026.
- How has Arcus Biosciences's operating income changed year-over-year?
- Arcus Biosciences's operating income decreased by 1100.0% year-over-year, from -$8M to -$96M.
- What is the long-term trend for Arcus Biosciences's operating income?
- Over 4 years (2021 to 2025), Arcus Biosciences's operating income has grown at a 63.5% compound annual growth rate (CAGR), from $54M to -$386M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Arcus Biosciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude